Humoral aspects of polymyositis/dermatomyositis

Modern Rheumatology

Volumn 10, Issue 4, 2000, Pages 199-206

  Hirakata, M ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti SRP antibodies; Antiaminoacyl tRNA synthetase; Interstitial lung disease; Myositis specific autoantibodies; Polymyositis dermatomyositis

Indexed keywords

EID: 85011712602     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/s101650070002     Document Type: Review

References (75)

1. Bohan A, Peter JB, Bowman BS, Pearson CM. A computer as-sisted analysis of 153 patients with polymyositis and dermatomyo-sitis. Medicine (Baltimore) 1977; 56: 255 – 86.
2. Reichlin M, Arnett FC. Multiplicity of antibodies in myositis sera. Arthritis Rheum 1984; 27: 1150 – 6.
3. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas MC, Plotz PH, et al. A new approach to the classification of idiopathic inflamma-tory myopathy: myositis-specific autoantibodies define useful ho-mogeneous patient groups. Medicine (Baltimore) 1991; 70: 360 – 74.
4. Targoff IN. Autoantibodies in polymyositis. Rheum Dis Clin North Am 1992; 18: 455 – 82.
5. Targoff IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 1994; 20: 857 – 80.
6. Hirakata M, Mimori T, Akizuki M, Craft J, Hardin JA, Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleopro-teins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992; 35: 449 – 56.
7. Dang CV, Dang CV. Higher eukaryotic aminoacyl-tFtNA syn-thetases in physiologic and pathologic states. Mol Cell Biochem 1986; 71: 107 – 20.
8. Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum 1980; 23: 881 – 8.
9. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl-tFtNA synthetase: a model for autoimmunity. Nature 1983; 304: 177 – 9.
10. Mathews MB, Reichlin M, Hughes GRV, Bernstein RM. Anti-threonyl-tFtNA synthetase, a second myositis-related autoanti-body. J Exp Med 1984; 160: 420 – 34.
11. Bunn CC, Bernstein RM, Mathews MB. Autoantibodies against alanyl-tFtNA synthetase and tRNAida coexist and are associated with myositis. J Exp Med 1096 163: 1281 – 91.
12. Targoff IN. Autoantibodies to aminoacyl-transfer RNA syn-thetases for isoleucine and glycine: two additional synthetases are antigenic in myositis. J Immunol 1990; 144: 1737 – 43.
13. Hirakata M, Suwa A, Nagai S, Kron MA, Trieu EP, Mimori T, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 1999; 162: 2315 – 20.
14. Eriani G, Delarue M, Poch O, Gangloff J, Moras D. Partition of tRNA synthetases into two classes based on mutually exclusive sets of sequence motifs. Nature 1990; 347: 203 – 6.
15. Cusack S, Hartlein M, Leberman R. Sequence, structural and evolutionary relationships between class 2 aminoacyl-tFtNA synthetases. Nucleic Acids Res 1991; 19: 3489 – 98.
16. Targoff IN, Trieu EP, Miller FW. Reaction of anti-0J autoantibod-ies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tFtNA synthetase. J Clin Invest 1993; 91: 2556 – 64.
17. Plotz PH. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 1983; ii: 824 – 6.
18. Rosa MD, Hendrick JP, Lerner MR, Steitz JA. A mammalian tRNAHIS containing antigen is recognized by the polymyositis-specific antibody anti-Jo-1. Nucleic Acids Res 1983; 11: 853 – 69.
19. Targoff IN, Reichlin M. Measurement of antibody to Jo-1 by ELISA and comparison to enzyme inhibitory activity. J Immunol 1987; 138: 2874 – 82.
20. Gelpi C, Kanterewicz E, Gratacos J, Targoff IN, Rodriguez-Sanchez JL. Coexistence of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum 1996; 39: 692 – 7.
21. Marguerie C, Bunn CC, Beynon HLC, Bernstein RM, Hughes JMB, So AK, et al. Polymyositis, pulmonary fibrosis and autoanti-bodies to aminoacyl-tFtNA synthetase enzymes. Q J Med 1990; 77: 1019 – 38.
22. Targoff IN, Arnett FC, Reichlin M. Antibody to threonyl-transfer RNA synthetase in myositis sera. Arthritis Rheum 1988; 31: 515 – 24.
23. Targoff IN, Arnett FC. Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tFtNA synthetase). Am J Med 1990; 88: 241 – 51.
24. Targoff IN, Trieu EP, Plotz H, Miller FW. Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease. Arthritis Rheum 1992; 35: 821 – 30.
25. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983; 26: 604 – 11.
26. Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB, Turner-Warwick M, et al. Anti-Jo-1 antibody: a marker for myosi-tis with interstitial lung disease. Br Med J 1984; 289: 151 – 2.
27. Oddis CV, Medsger TA Jr, Cooperstein LA. A subluxing arthr-opathy associated with the anti-Jo-1 antibody in polymyositis/ dermatomyositis. Arthritis Rheum 1990; 33: 1640 – 5.
28. Hirakata M, Nakamura K, Kaburaki J, Suwa A, Mimori T, Kanazawa M, et al. Interstitial lung disease in patients with connec-tive tissue diseases (in Japanese). Jpn J Thorac Dis 1995; 33: 268 – 76.
29. Hirakata M, Suwa A, Satoh S, Mimori T, Nagai S, Kitaichi M, et al. Circulating KL-6 (MUC1 mucin) in patients with interstitial lung disease and anti-asparaginyl-tFtNA synthetase autoantibodies. Arthritis Rheum 1999;42(Suppl.): S111.
30. Hirakata M, Nagai S, Suwa A, Satoh S, Hama N, Ohsone Y, et al. Histological features of interstitial lung disease in patients with anti-glycyl tFtNA synthetase autoantibodies. Arthritis Rheum 1998;41(Suppl.): 5323.
31. Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tFtNA synthetase in the absence of clinically apparent myositis. Semin Arthritis Rheum 1996; 26: 459 – 67.
32. Hirakata M, Nakamura K, Okano Y, Suwa A, Inada S, Akizuki M, et al. Anti-alanyl tFtNA synthetase (PL-12) antibodies are asso-ciated with interstitial lung disease in Japanese patients. Arthritis Rheum 1995;38(Suppl.): S146.
33. Walter P, Lingappa VR. Mechanism of protein translocation across the endoplasmic reticulum membrane. Annu Rev Cell Biol 1986; 2: 499 – 516.
34. Reeves WH, Nigam SK, Blobel G. Human autoantibodies reactive with the signal recognition particle. Proc Natl Acad Sci USA 1986; 83: 9507 – 11.
35. Okada N, Mimori T, Mukai R, Kashiwagi H, Hardin JA. Charac-terization of human autoantibodies that selectively precipitate the 75L RNA component of the signal recognition particle. J Immunol 1987; 138: 3129 – 223.
36. Targoff IN, Johnson AE, Miller FW. Antibody to signal recogni-tion particle in polymyositis. Arthritis Rheum 1990; 33: 1361 – 70.
37. Hirakata M, Matsuura Y, Suwa A, Satoh S, Hama N, Ohsone Y, et al. Immunological and histopathological features of patients with anti-SRP autoantibodies. Arthritis Rheum 1997;40(Suppl.): 5146.
38. Bernstein RM, Bunn CC, Hughes GRV, Francoeur AM, Mathews MB. Cellular protein and RNA antigens in autoimmune disease. Mol Biol Med 1984; 2: 105 – 20.
39. Targoff IN, Hanas J. The polymyositis-associated Fer antigen is elongation factor la. Arthritis Rheum 1989;32(Suppl.): 581.
40. Targoff IN, Arnett FC, Berman L, O'Brien C, Reichlin M. Anti-KJ: a new antibody associated with myositis/lung syndrome that reacts with a translation-related protein. J Chin Invest 1989; 84: 162 – 72.
41. Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum 1985; 28: 796 – 803.
42. Targoff IN, Nilasena DS, Trieu EP, Arnett FC, Pachman LM, Callen JP, et al. Clinical features and immunologic testing of pa-tients witn anti-Mi-2 antibodies. Arthritis Rheum 1990;33(Suppl.): S72.
43. Seeling HP, Moosbrugger I, Ehrfeld H, Fink T, Renz M, Genth E. The major dermatomyositis-specific Mi-2 autoantigen is a pre-sumed helicase involved in transcriptional activation. Arthritis Rheum 1995; 38: 1389 – 99.
44. Ge Q, Nilasena DS, O'Brien CA, Frank MB, Targoff IN. Molecu-lar analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest 1995; 96: 1730 – 7.
45. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic dis-ease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148 – 59.
46. Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connec-tive tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore) 1980; 59: 239 – 48.
47. Lundberg I, Nennesmo I, Hedfors E. A clinical, serological, and histopathological study of myositis patients with and without anti-FtNP antibodies. Semin Arthritis Rheum 1992; 22: 127 – 38.
48. Lerner MR, Steitz JA. Antibodies to small nuclear FtNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 1979; 76: 5495 – 9.
49. Pettersson I, Hinterberger M, Mimori T, Gottlieb E, Steitz JA. The structure of mammalian small nuclear ribonucleoproteins. Identifi-cation of multiple protein components reactive with anti-(U1) ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem 1984; 259: 5907 – 14.
50. Takeda Y, Wang GS, Wang RJ, Anderson SK, Pettersson I, Amaki S, et al. Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to inves-tigate the clinical significance of autoantibodies to these polypep-tides. Clin Immunol Immunopathol 1989; 50: 213 – 30.
51. Query CC, Keene JD. A human autoimmune protein associated with Ul RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell 1987; 51: 211 – 20.
52. Guldner HH, Netter HJ, Szostecki C, Jaeger E, Will H. Human anti-p68 autoantibodies recognize a common epitope of Ul RNA containing small nuclear ribonucleoprotein and influenza B virus. J Exp Med 1990; 171: 819 – 29.
53. Mimori T, Hinterberger M, Pettersson I, Steitz JA. Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with sclero- derma-polymyositis overlap syndrome. J Biol Chem 1984; 259: 560 – 5.
54. Habets WJ, Sillekens FIG, Hoet MH, McAllister G, Lerner MR, van Venrooij WJ. Small nuclear RNA-associated proteins are immunologically related as revealed by mapping of autoimmune reactive B-cell epitopes. Proc Natl Acad Sci USA 1989; 86: 4674 – 8.
55. Craft J, Mimori T, Olsen TL, Hardin JA. The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes. J Chin Invest 1987; 81: 1716 – 24.
56. Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S, Homma M. Characterization of a high molecular weight acidic nuclear pro-tein recognized by autoantibodies in sera from patients with poly-myositis-scleroderma overlap. J Chin Invest 1981; 68: 611 – 20.
57. Reeves WH. Use of monoclonal antibodies for the characteriza-tion of novel DNA-binding proteins recognized by human autoim-mune sera. J Exp Med 1985; 161: 18 – 39.
58. Yaneva M, Arnett FC. Antibodies against Ku protein in sera from patients with autoimmune diseases. Clin Exp Immunol 1989; 76: 366 – 72.
59. Hirakata M, Suwa A, Kuwana M, Okano Y, Mimori T, Hardin JA, et al. Anti-Ku autoantibodies are associated with the DPB1*0501 gene. Arthritis Rheum 1994;37(Suppl.): 574.
60. Mimori T, Hardin JA, Steitz JA. Characterization of the DNA-binding protein antigen Ku recognized by autoantibodies from patients with rheumatic disorders. J Biol Chem 1986; 261: 2274 – 8.
61. Mimori T, Hardin JA. Mechanism of interaction between Ku protein and DNA. J Biol Chem 1986; 261: 10375 – 9.
62. Dvir A, Peterson SR, Knuth MW, Lu H, Dynan WS. Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. Proc Natl Acad Sci USA 1992; 89: 11920 – 4.
63. Gottlieb TM, Jackson SP. The DNA-dependent protein kinase. Requirement for DNA ends and association with Ku antigen. Cell 1993; 72: 131 – 42.
64. Rathmell WK, Chu G. Involvement of the Ku autoantigen in the cellular response to DNA double-strand breaks. Proc Natl Acad Sci USA 1994; 91: 7623 – 7.
65. Taccioli GE, Gottlieb TM, Blunt T, Priestley A, Demengeot J, Mizuta R, et al. Ku 80: product of the XRCC5 gene and its role in DNA repair and V(D)J recombination. Science 1994; 265: 1442 – 5.
66. Smider V, Rathmell WK, Lieber MR, Chu G. Restoration of X-ray resistance and V(D)J recombination in mutant cells by Ku cDNA. Science 1994; 266: 288 – 91.
67. Suwa A, Hirakata M, Takeda Y, Okano Y, Mimori T, Inada S, et al. Autoantibodies to DNA-dependent protein kinase. Probes for the catalytic subunit. J Clin Invest 1996; 97: 1417 – 21.
68. Wolfe JF, Adelstein E, Sharp GC. Antinuclear antibody with dis-tinct specificity for polymyositis. J Clin Invest 1977; 59: 176 – 8.
69. Oddis CV, Okano Y, Rudert WA, Truce° M, Duquesnoy RJ, Medsger TA Jr. Serum autoantibody to the nudeolar antigen PM-Sd: clinical and immunogenetic associations. Arthritis Rheum 1992; 35: 1211 – 7.
70. Reichlin M, Maddison PJ, Targoff IN, Bunch TW, Arnett FC, Sharp GC, et al. Antibodies to a nudear/nucleolar antigen in patients with polymyositis-overlap syndrome. J Chin Immunol 1984; 4: 40 – 4.
71. Reimer G, Scheer U, Peters JM, Tan EM. Immunolocalization and partial characterization of a nucleolar antigen PM-Sd. Clinical and immunogenetic associations. Arthritis Rheum 1992; 35: 1211 – 7.
72. Gelpi C, Alguero A, Angeles Martinez M, Vidal S, Juarez C, Rodriguez-Sanchez JL. Identification of protein components reac-tive with anti-PM-Scl autoantibodies. Clin Exp Immunol 1990; 81: 59 – 64.
73. Walker EJ, Jeffray PD. Polymyositis and molecular mimicry: a mechanism of autoimmunity. Lancet 1986; i: 605 – 7.
74. Walker EJ, Jeffray PD. Sequence homology between encephalomyocarditis virus protein VP1 and histidyl-tFtNA syn-thetase supports a hypothesis of molecular mimicry in polymyosi-tis. Med Hypotheses 1988; 25: 21 – 5.
75. Ge Q, Trieu EP, Targoff IN. Primary structure and functional expression of human glycyl-tFtNA synthetase, an autoantigen in myositis. J Biol Chem 1994; 269: 28790 – 7.